NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 67 filers reported holding NURIX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,579,000 | -40.6% | 677,143 | -34.3% | 2.31% | -42.8% |
| Q1 2022 | $14,441,000 | -58.6% | 1,030,798 | -14.5% | 4.04% | -43.7% |
| Q4 2021 | $34,908,000 | -3.4% | 1,205,798 | 0.0% | 7.18% | +35.0% |
| Q3 2021 | $36,126,000 | +12.9% | 1,205,798 | 0.0% | 5.32% | +23.0% |
| Q2 2021 | $31,990,000 | -16.9% | 1,205,798 | -2.6% | 4.32% | -6.2% |
| Q1 2021 | $38,504,000 | -50.1% | 1,238,456 | -47.3% | 4.61% | -45.0% |
| Q4 2020 | $77,196,000 | -5.8% | 2,347,804 | -0.0% | 8.38% | -54.6% |
| Q3 2020 | $81,969,000 | – | 2,348,014 | – | 18.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |